Europe's PRAC concludes ambroxol risk is "small"

15 January 2015 - Deborah Wilkes

Archived

The risk of allergic reactions to medicines containing ambroxol or bromhexine is "small", the European Union's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded following a safety review.

Click tags below for more information on topics:

FAMHP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: